JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on April 11, 2003
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
278/16/14306    most recent
M210502200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Belle, I.
Right arrow Articles by Adamson, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Belle, I.
Right arrow Articles by Adamson, E. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 31, 2003
J. Biol. Chem, 10.1074/jbc.M210502200
Submitted on October 14, 2002
Revised on January 31, 2003
Accepted on January 31, 2003

In vivo cloning and characterization of a new growth suppressor protein TOE1 as a direct target of Egr1

Ian de Belle, Jie-Xin Wu, Sabina Sperandio, Dan Mercola, and Eileen D. Adamson

La Jolla Cancer Research Center, The Burnham Institute, La Jolla, CA 92037

Corresponding Author: idebelle{at}burnham.org

Egr1, an immediate early transcription factor responds to diverse stimuli and affects gene transcription to accomplish its biological effects. One important effect of Egr1 expression is to decrease the growth and tumorigenic potential of several tumor cell types. To identify important Egr1 target genes we have adapted a methodology involving formaldehyde-induced protein/DNA crosslinking, chromatin immunoprecipitation and multiplex PCR. Using this approach, we report the cloning of a new Egr1 target gene which is able to account for, at least in part, the growth inhibitory activity of Egr1. We have named this new protein TOE1 for Target Of Egr1


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
E. Wagner, S. L. Clement, and J. Lykke-Andersen
An Unconventional Human Ccr4-Caf1 Deadenylase Complex in Nuclear Cajal Bodies
Mol. Cell. Biol., March 1, 2007; 27(5): 1686 - 1695.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Ferraro, G. Bepler, S. Sharma, A. Cantor, and E. B. Haura
EGR1 Predicts PTEN and Survival in Patients With Non-Small-Cell Lung Cancer
J. Clin. Oncol., March 20, 2005; 23(9): 1921 - 1926.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
C. L. WILL, C. SCHNEIDER, M. HOSSBACH, H. URLAUB, R. RAUHUT, S. ELBASHIR, T. TUSCHL, and R. LUHRMANN
The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome
RNA, June 1, 2004; 10(6): 929 - 941.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.